TT treatment lowered blood glucose, triglyceride, total cholesterol, and insulin levels, ameliorated hyperglycemia and hyperlipidemia, and exhibited protection against HFD-induced insulin resistance. The gene discussed is INS; the disease is Insulin resistance.